Stock 600488 TIANJIN TIANYAO PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Tianjin Tianyao Pharmaceuticals Co., Ltd.

Equities

600488

CNE000001840

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 05/07/2024 am IST 		5-day change 1st Jan Change
3.52 CNY +3.23% Intraday chart for Tianjin Tianyao Pharmaceuticals Co., Ltd. +2.62% -28.16%
09/05 Jinyao Pharmaceutical Gets Nod to Market Betamethasone Dipropionate in Europe MT
26/04 Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jinyao Pharmaceutical Gets Nod to Market Betamethasone Dipropionate in Europe
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Jinyao Pharma's Unit Gets Approval to Market Compound Ipratropium Bromide Solution
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Jinyao Pharma Unit's Fluconazole Chloride Passes Regulatory Evaluation
Jinyao Pharma Unit's Metoclopramide Hydrochloride Injection Passes Regulatory Evaluation
Jinyao Pharmaceutical's Drugs Chosen for China's Centralized Procurement Bid
Jinyao Pharmaceutical Gets Nod to Market Travoprost
Tianyao Pharma’s Brain Injury Drug Passes Generic Drug Consistency Test
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jinyao Pharmaceutical Unit's Methylcobalamin Injection Passes Drug Regulator's Evaluation
Jinyao Pharmaceutical Gets Nod to Market Two Raw Drug Materials
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jinyao Pharmaceutical Unit's Tumor Drug Passes Regulatory Evaluation
Jinyao Pharmaceutical Gets Nod for Marketing Application of Raw Drug Material
Tianjin Tianyao Pharma Receives 35 Million Yuan in Government Subsidies
Tianyao Pharma Registers Inhalation Drug
Jinyao Pharmaceutical's Unit Gets Nod to Topical Cream's Registration
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianyao Pharma Joins Bid to Have Edema Drug Added to China’s Drug Procurement Program
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600488 Stock
  4. News Tianjin Tianyao Pharmaceuticals Co., Ltd.
  5. Other languages